RecruitingNCT04421248
Testing brain measures of methylphenidate response in children with ADHD
About this title
Read the official source — NCT04421248Medication studyAges 8–12United States
Understand this study
Who could participate?
Listed age limits: 8 years to 12 years.
What will I do during this study?
Children with ADHD (attention deficit hyperactivity disorder) receive a single dose of methylphenidate and placebo (an inactive comparison treatment) in a randomized crossover study, alongside typically developing children who are comparison participants. The study uses TMS (transcranial magnetic stimulation)-based brain measures to examine attention and impulse-control biomarkers.
- Listed locations
- Baltimore and 1 more locationSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: September 1, 2020
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 214
- Sponsor
- Donald Gilbert, MD, MS, FAAN, FAAP
- Sponsor type
- Individual investigator
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- From 8 Years to 12 Years
- Official registry ID
- NCT04421248
- Official title
Show the full official title
Anomalous Motor System Physiology in Attention Deficit Hyperactivity Disorder: Biomarker Validation and Modeling Domains of Function
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Baltimore · Cincinnati
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Donald Gilbert, MD, MS, FAAN, FAAP.
Does this study involve medication?
Yes. The study involves medication, including Methylphenidate and Placebo.
Who can participate?
Listed age limits: 8 years to 12 years.
Is this study still recruiting?
The registry lists this study as recruiting.
